Announced
Financials
Tags
drug discovery
Biotechnology
Domestic
Private
Friendly
Single Bidder
Acquisition
Pending
United States
Majority
Private Equity
Synopsis
QHP Capital, an investor in healthcare companies in the middle market, agreed to acquire Applied StemCell, a biotechnology company providing animal and cell line models as tools for drug discovery and diagnostics. Financial terms were not disclosed. “Applied StemCell is dedicated to supporting the biopharmaceutical and research sectors in the pursuit of delivering transformative regenerative medicine treatments and cell therapy products. We are delighted to have the partnership with QHP Capital. ASC’s technology and capabilities combined with QHP’s strategic network and deep industry knowledge will help us accelerate our vision to enable the future cell gene therapy market by creating iPSCs and cell products that present the highest efficacy, greatest safety, and the most accelerated and scalable manufacturing,” Ruby Chen-Tsai, Applied StemCell CEO.
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.